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Cell surface metalloproteases coordinate signaling
during development, tissue homeostasis, and dis-
ease. TACE (TNF-a-converting enzyme), is respon-
sible for cleavage (‘‘shedding’’) of membrane-teth-
ered signaling molecules, including the cytokine
TNF, and activating ligands of the EGFR. The traf-
ficking of TACE within the secretory pathway re-
quires its binding to iRhom2, which mediates the
exit of TACE from the endoplasmic reticulum. An
important, but mechanistically unclear, feature of
TACE biology is its ability to be stimulated rapidly
on the cell surface by numerous inflammatory and
growth-promoting agents. Here, we report a role for
iRhom2 in TACE stimulation on the cell surface.
TACE shedding stimuli trigger MAP kinase-depen-
dent phosphorylation of iRhom2 N-terminal cyto-
plasmic tail. This recruits 14-3-3 proteins, enforcing
the dissociation of TACE from complexes with
iRhom2, promoting the cleavage of TACE substrates.
Our data reveal that iRhom2 controls multiple as-
pects of TACE biology, including stimulated shed-
ding on the cell surface.
INTRODUCTION
A major mechanism of cellular communication involves ‘‘shed-
ding’’: the stimulated proteolytic release of signaling molecules
from the plasma membrane. The TNF-a-converting enzyme
(TACE), also called ADAM17 (a disintegrin and metallopro-
tease-17), is a prominent sheddase with more than 80 cellular
substrates (Gooz, 2010). Mutant mouse studies emphasize the
essential role of TACE in inflammation: it sheds the inflammatory
cytokine, tumor necrosis factor (TNF) (Horiuchi et al., 2007).
TACE also plays an essential physiological role in growth factorCe
This is an open access article undsignaling, by shedding multiple activating ligands of the
epidermal growth factor receptor (EGFR), a receptor important
for epithelial development, homeostasis, and cancer (Peschon
et al., 1998).
TACE is synthesized as a catalytically inactive precursor in the
endoplasmic reticulum (ER). To be proteolytically active, TACE
must undergo a maturation step, which occurs in the trans-Golgi
network, where pro-protein convertases cleave off TACE’s inhib-
itory N-terminal prodomain, rendering it basally active (Schlo¨n-
dorff et al., 2000). The work of several groups, including ours,
recently identified polytopic membrane proteins called iRhoms
as essential regulators of TACE maturation (Adrain et al., 2012;
Siggs et al., 2012; Christova et al., 2013). In iRhom null cells,
TACE is retained in the ER, fails to undergo prodomain removal,
and is consequently proteolytically inactive.
As overexpressed iRhoms are predominantly ER localized
(Zettl et al., 2011), the current working hypothesis is that iRhoms
mediate the ER-to-Golgi trafficking of TACE (Adrain and
Freeman, 2012). However, several observations are incongruent
with this model: first, cross-linking experiments show that iRhom
binds efficiently to mature TACE, indicating that the molecules
still interact following prodomain removal in the trans-Golgi
network (Adrain et al., 2012). Second, endogenous iRhom2 con-
tains endoglycosidase H-insensitive glycans, indicating that
it traffics beyond the ER (Adrain et al., 2012). Moreover, over-
expressed iRhoms localize to the plasma membrane (Maney
et al., 2015).
The cell surface sheddase activity of TACE is subject to
another important layer of regulation: stimulation by various
signaling pathways. TACE stimulation is involved in inflamma-
tion, tissue damage, and cancer; stimulatory agents include
the phorbol ester phorbol 12-myristate 13-acetate (PMA) (Arri-
bas et al., 1996), cytokine receptors (Hall and Blobel,
2012),Toll-like receptors (Brandl et al., 2010), and G protein-
coupled receptors (Prenzel et al., 1999; Wetzker and Bo¨hmer,
2003). Many stimuli that activate TACE converge on the cyto-
plasm, activating kinases, including members of the MAP
(mitogen-activated protein kinase) kinase family, that controlll Reports 21, 745–757, October 17, 2017 ª 2017 The Authors. 745
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Figure 1. iRhom2 Is Phosphorylated in
Response to TACE-Activating Stimuli
(A) Schematic envisaging iRhom2 phosphorylation
as a signal integrator for TACE-activating stimuli.
(B and C) Phos-tag gels show that endogenous
iRhom2 is phosphorylated in bone marrow-derived
macrophages (BMDMs) stimulated with LPS (B) and
(C) poly(I:C).
(D) The mobility shift in iRhom2 is reverted by
phosphatase treatment.
(E) Endogenous iRhom2 is phosphorylated in
BMDMs stimulated with the G protein-coupled re-
ceptor ligand gastrin-releasing peptide (GRP).
(F) Endogenous iRhom2 is phosphorylated in
response to PMA and LPS in RAW264.7 macro-
phages.
(G) HA-tagged mouse iRhom2, stably expressed
in HEK293ET cells, is phosphorylated in response
to PMA.
Throughout, a white arrowhead denotes phos-
phorylated iRhom2 and a black arrowhead non-
phosphorylated iRhom2. p97 immunoblots are a
loading control and pERK (phosphorylated ERK)
a positive control for stimulation. Here and
throughout, cells were stimulated for 15 min with
LPS (1 mg/mL), GRP (200 ng/mL), and PMA (1 mM)
and for 60 min with poly(I:C) (1 mg/mL). See also
Figure S1.release of several endogenous TACE substrates, including TNF
and EGFR ligands (Dı´az-Rodrı´guez et al., 2002; Rousseau
et al., 2008; Xu and Derynck, 2010; Scott et al., 2011; Sommer
et al., 2016). There is an emerging consensus that TACE-acti-
vating stimuli enforce rearrangements in the ectodomain of
TACE, resulting in enhanced TACE substrate cleavage (Le Gall
et al., 2010). This process is negatively regulated by cell surface
protein disulfide isomerases, and positively regulated by the
externalization of phosphatidylserine (PS) to the outer leaflet of
the plasma membrane (D€usterho¨ft et al., 2013; Sommer et al.,
2016).
A complication in envisaging how stimuli are transduced to
TACE is the conflicting evidence for the importance of the
TACE cytoplasmic tail. The cytoplasmic tail of TACE is phos-
phorylated in response to shedding stimulants, but there is no
consensus concerning the impact of these phosphorylation
events (Fan and Derynck, 1999; Dı´az-Rodrı´guez et al., 2002;
Fan et al., 2003; Soond et al., 2005; Xu and Derynck, 2010; Scott
et al., 2011; Xu et al., 2012). Indeed, several studies have shown
that the TACE cytoplasmic tail is not required for TACE stimula-
tion (Le Gall et al., 2010; Hall and Blobel, 2012), suggesting that
another transmembrane protein containing a cytoplasmic tail
transduces cytoplasmic stimulatory signals to the extracellular
protease domain of TACE.
iRhom2 has a longN-terminal cytoplasmic tail that is predicted
to be intrinsically disordered, decorated with signatures of a
signaling hub, including predicted 14-3-3 binding sites, pre-
dicted ERK (extracellular signal-regulated kinase) kinase dock-
ing sites (Roux and Blenis, 2004) (Figure S1A), and multiple746 Cell Reports 21, 745–757, October 17, 2017potentially phosphorylated residues (Figure 1A; Table S1).
Recently, Maney et al. (2015) showed that TACE activity was
enhanced in cells expressing mutants of iRhom truncated within
their cytoplasmic tails, but the mechanistic basis of the phenom-
enonwas unexplored. Additional evidence for a regulatory role of
the iRhom2 N terminus comes from the identification of gain of
function mutations in the N terminus of human iRhom2 that
enhance TACE sheddase activity (Maney et al., 2015) and cause
tylosis with esophageal cancer, a keratinocyte hyperproliferative
condition (Blaydon et al., 2012).
Here, we identify that phosphorylation of the iRhom2 cyto-
plasmic tail plays a central and essential role in the regulation
of TACE stimulation.
RESULTS
iRhom2 Is Phosphorylated in Response to Physiological
TACE-Activating Stimuli
To test the hypothesis that iRhom2 is an essential co-factor for
TACE stimulation (Figures 1A and S1A), we analyzed iRhom2
phosphorylation in response to a panel of physiological TACE-
activating stimuli. To detect phosphorylation of iRhom2, we sup-
plemented SDS-PAGE gels with Phos-tag, a compound that
slows the electrophoretic mobility of phosphorylated proteins.
As shown in Figures 1B and 1C, treatment of cells with the
Toll-like receptor ligands lipopolysaccharide (LPS) and poly(I:C),
stimuli that provoke the shedding of TNF, induced phosphoryla-
tion of endogenous iRhom2 in primary murine bone marrow-
derived macrophages. Phosphatase treatment of lysates from
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Figure 2. iRhom2 Phosphorylation De-
pends on MAP Kinases Downstream of
Toll-like Receptor Signaling
(A) Schematics illustrating how signaling down-
stream of TLR3/4, GPCRs, and PMA converges on
MAPK activation. Inhibitors are highlighted in
red. Adapted from Goldsmith and Dhanasekaran
(2007); Steinberg (2008), and Oda and Kitano
(2006).
(B) A combination of ERK- and p38-MAPK in-
hibitors prevent endogenous iRhom2 phosphory-
lation in LPS-stimulated BMDMs.
(C) MAPK inhibitors (MEK1/2, JNK, and p38)
prevent endogenous iRhom2 phosphorylation in
poly(I:C)-stimulated BMDM.
Throughout, cells were pre-treated for 30 min with
inhibitors (2.5 mM PD184352 [MEK1/2 inhibitor],
5 mM SP600125 [JNK inhibitor], 1 mM SB 202190
[p38 inhibitor]) followed by LPS (15min) or poly(I:C)
(60 min) treatment.LPS-stimulated macrophages confirmed that the slower migra-
tion of iRhom2 was indeed caused by phosphorylation (Fig-
ure 1D). We next looked at activation of a G protein-coupled re-
ceptor, a pathway linked to EGFR transactivation (Wetzker and
Bo¨hmer, 2003). We found that the gastrin-releasing peptide re-
ceptor, which is implicated in EGFR-associated cancers, also
triggered iRhom2 phosphorylation (Figure 1E). The phorbol ester
PMA, a stimulus commonly used to trigger TACE-mediated sub-
strate shedding, also induced endogenous iRhom2 phosphory-
lation in RAW264.7 macrophages (Figure 1F) and HEK293ET
cells stably expressing HA-tagged mouse iRhom2 (Figure 1G).
In summary, iRhom2 is phosphorylated in response to range of
physiological stimuli known to rapidly induce TACE sheddase
activity.
iRhom2 Phosphorylation Is Dependent on MAP Kinases
We next addressed which kinases were potentially involved
in iRhom2 phosphorylation. The major part of iRhom2 that
is exposed to the cytoplasm, accessible to kinases, is its
extended N-terminal cytoplasmic tail (Figure 1A). As MAP ki-
nases can be activated by the TACE stimuli (Dı´az-Rodrı´guez
et al., 2002; Yamamoto et al., 2002; Scott et al., 2011; Czepie-
lewski et al., 2012) that we here show trigger iRhom2 phos-
phorylation (Figure 1), we focused on this kinase family. LPS
activation of Toll-like receptor-4 converges on MAP kinases
(Figure 2A). To examine the potential role of these kinases in
iRhom2 phosphorylation, we used a pool of inhibitors target-
ing MEK1/2, whose downstream kinase targets are ERK1/2,
plus inhibitors for JNK or p38 (Figures 2A and 2B). Although
no single inhibitor blocked phosphorylation, a combination
of p38 and MEK1/2 inhibitors abolished LPS-induced phos-
phorylation of endogenous iRhom2 (Figure 2B). In contrast, in-
hibitors of all three MAPK were required to block iRhom2
phosphorylation in response to Toll-like receptor-3 activation
by poly(I:C) (Figure 2C). We conclude that MAP kinases
are required for phosphorylation of endogenous iRhom2 in
response to Toll-like receptor activation, stimuli that promote
TNF shedding.Rapid Stimulation of TACE Shedding Requires
Phosphorylation of iRhom2
In contrast to the slow rate of TACE trafficking from the ER to the
Golgi (Schlo¨ndorff et al., 2000), TACE stimulation occurs with
rapid kinetics, potentially acting mechanistically to control rear-
rangements in the extracellular domains of TACE or the access
of TACE’s active site to substrates (Le Gall et al., 2010).
We next investigated the impact of iRhom2 phosphorylation on
its ability to regulate TACE activity. Notably, several high
throughput phosphoproteomic studies detected phosphory-
lated residues (Table S1) within the iRhom2 cytoplasmic tail,
triggered in response to LPS and to G protein-coupled receptor
agonists known to stimulate TACE activity (Christensen et al.,
2010; Weintz et al., 2010). As these phosphorylation events
were not confirmed biochemically, nor was their functional rele-
vance explored, we examined this in depth.
iRhom1/iRhom2 double-knockout (DKO) mouse embryonic fi-
broblasts (MEFs) are devoid of TACE activity and cannot support
stimulated TACE shedding (Christova et al., 2013). To examine
the functional impact of blocking iRhom2 phosphorylation on
the regulation of TACE, we constructed a compound mutant in
which all 15 putative phosphorylation sites identified by the
phosphoproteomic screens (Table S1) were mutated to alanine
to block the ability of the protein to be phosphorylated. This
phosphorylation-dead mutant (hereafter referred to as iRhom2
Dead for simplicity) could not be phosphorylated in response
to PMA, indicating that the relevant sites were among the engi-
neered mutations (Figure 3A).
To examine the ability of the iRhom2 Dead mutant to rescue
TACE stimulation, we assessed its capacity to support shedding
of the EGFR ligand transforming growth factor alpha fused to
alkaline phosphatase (TGF-a-AP) into culture medium (Sahin
et al., 2004). A time-course analysis of PMA-stimulated TGF-
a-AP shedding revealed that, as expected (Le Gall et al.,
2010), induction of TACE shedding occurred rapidly, within
5–20 min (Figure 3B). Notably, although TGF-a-AP shedding
was rescued by expression of wild-type (WT) iRhom2, the
Dead mutant was significantly impaired in its ability to rescueCell Reports 21, 745–757, October 17, 2017 747
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Figure 3. iRhom2 Cytoplasmic Tail Phosphorylation Is Required for Rapid Induction of TACE-Dependent Shedding
(A) iRhom2 Dead mutant stably expressed in HEK293ET cells is not phosphorylated in response to PMA.
(B) PMA-stimulated TGF-a-AP shedding requires iRhom2 phosphorylation. iRhom1/2 DKO MEFs were transduced with iRhom2 WT, iRhom2 Dead mutant, or
empty vector (EV) retrovirus.
(C) Marimastat (MM; 5 mM) was used to inhibit shedding by metalloproteases.
(D) The ADAM10-specific inhibitor GI254023X (GI; 1 mM, 60 min) did not affect TGF-a-AP shedding in rescue assays in iRhomDKOMEFs expressing WT iRhom2
versus the Dead mutant or empty vector.
(E) Ionomycin (IO; 2.5 mM, 60 min) stimulated shedding of betacellulin-AP (BTC-AP) was unaffected by iRhom2 phosphorylation.
(F) iRhom2 KO BMDMs transduced with iRhom2 Dead retrovirus are defective in the shedding of TNF after 3 hr of LPS stimulation.
Data are presented as mean ± SEM. See also Table S1.shedding in iRhom DKO MEFs, at all time points (Figure 3B). At
the later time points, chronic exposure of cells to PMA may
activate iRhom-independent shedding pathways, explaining
the incomplete loss of shedding in the Deadmutant. Importantly,
the effect observed was specific to TACE: TGF-a-AP shedding
was blocked by the metalloprotease inhibitor Marimastat
(MM) (Figure 3C) but not by the ADAM10-selective inhibitor
GI254023X (Ludwig et al., 2005) (Figure 3D). Moreover, ionomy-
cin (IO)-triggered shedding of alkaline-phosphatase fused to be-
tacellulin (BTC), a substrate of ADAM10, the metalloprotease
closely related to TACE, was unaffected by the iRhom2 Dead
mutant (Figure 3E). In summary, our results reveal that iRhom2
phosphorylation is essential for the rapid activation of TACE.
We validated our findings using an alternative and physiolog-
ically relevant paradigm of TACE activation. In contrast to
models of TACE shedding that rely on rapid cleavage of pre-ex-
isting substrate, in macrophages, the shedding of TNF is biolog-
ically distinct: it first requires TNF transcription and translation, in
response to Toll-like receptor activation. As iRhom2 is necessary
and sufficient for TACEmaturation inmacrophages (Adrain et al.,748 Cell Reports 21, 745–757, October 17, 20172012), we used retrovirus to transduce iRhom2 WT, or the Dead
mutant, into primary macrophages of iRhom2 knockout (KO)
mice. Similar to the MEF experiments, expression of the iRhom2
Dead mutant was less efficient in restoring LPS-triggered TNF
shedding than WT iRhom2 (Figure 3F). In summary, phosphory-
lation of iRhom2 is crucial for the rapid stimulation of TACE
activity by phorbol esters and for the more delayed release of
endogenous TNF following Toll-like receptor stimulation.
iRhom2 Phosphorylation at Ser 83 Recruits 14-3-3
Proteins, Controlling TACE Stimulation
Proteins are often phosphorylated at multiple positions, some-
times by several kinases (Cohen, 2000). To learn more about
which residues within iRhom2 promote TACE sheddase activity,
we deconvoluted the iRhom2 Dead compound mutant into three
separate mutant clusters: 1–130, 131–212, and 213–381, on an
otherwise WT, full-length iRhom2 background (Figure 4A). In
TGF-a-AP-shedding assays in DKO MEFs, expression of the
1–130mutant, which contains the N-terminal five potential phos-
phorylation sites, still failed to restore TACE activity, indicating
AD
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that it contained the functionally relevant phosphorylation sites
(Figure 4B). The 131–212 and 213–381 mutants exhibited a
reduced, although not statistically significant, ability to support
shedding compared with WT iRhom2, although all mutants
were expressed at equivalent levels (Figure 4C).
To obtain deeper insights into the specific residues within the
iRhom2 cytoplasmic tail that were phosphorylated in response
to PMA in our model, we performed mass spectrometry on im-
munoprecipitates from HEK293ET cells expressing HA-tagged
WT mouse iRhom2 versus the iRhom2 Dead mutant. This re-
vealed that iRhom2 was phosphorylated at multiple serines
upon PMA stimulation (Figure 4D), including two residues, S60
(Figure 4E) and S83 (Figure 4F), that mapped within the 1–130
mutant cluster that significantly impaired PMA-induced shed-
ding (Figure 4B). When we examined each identified phosphory-
lation site individually, we found that only blocking phosphoryla-
tion at S83 significantly impaired shedding (Figure 4G). In
contrast, the other mutants including S60A, impaired shedding
only modestly, indicating that, at least when scrutinized individ-
ually, these residues play a minor role in shedding (Figures 4G
and 4H).
To examine the functional impact of iRhom2 phosphorylation,
we performedmass spectrometry analysis to determine whether
the cohort of iRhom2-interacting proteins changed upon phos-
phorylation. These experiments revealed 11 proteins, whose
binding to iRhom2 was altered upon PMA stimulation, including
several 14-3-3 protein isoforms, that function as molecular
switches, whose recruitment is often contingent on phosphory-
lation of their binding proteins (Figures 5A and S1B). The binding
of 14-3-3 proteins to iRhom2 appeared plausible because 14-
3-3 recruitment motifs (Madeira et al., 2015) are found at
phosphoserines S60, S83, and S359 within the iRhom2 cyto-
plasmic tail (Figure S1A). Co-immunoprecipitation experiments
confirmed that 14-3-3 proteins were recruited to iRhom2 upon
PMA stimulation (Figure 5B) dependent on phosphorylation at
S83 (Figure 5C). As S83 is important for shedding (Figure 4G),
this highlights a connection between the phosphorylation-
dependent recruitment of 14-3-3 and TACE stimulation.
To test directly the role of 14-3-3 proteins in TACE stimulation,
we constructed a mutant in which the well-characterized 14-3-3
recruitment motif R18 (Masters and Fu, 2001) was added to the
N terminus of the cytoplasmic tail of the iRhom2 Dead mutant
(Figure 5D). Interestingly, this mutant, which bound to 14-3-3
proteins constitutively in the absence of PMA stimulation (Fig-
ure 5E), exhibited a significantly increased capacity to facilitate
TACE shedding activity (Figure 5F), without increasing the poolFigure 4. Phosphorylation of iRhom2 at Serine 83 Is Essential for TACE
(A) Schematic of the putative iRhom2 phosphorylated residues that were mutate
(B) The putative phosphorylated residues located within amino acids 1–130 of iRho
DKO MEFs stably expressing the specified mutants. PMA (60 min) was used to s
(C) The iRhom2 non-phosphorylatable mutants (used in B) had equivalent expres
(D) Mass spectrometry analysis identified six phosphorylation sites in mouse iRho
inducible (15 min PMA). FC, fold change relative to WT cells treated with DMSO.
(E and F) Mass spec analysis of iRhom2 phosphorylation at S60 (E) or S83 (F).
(G) iRhom1/2 DKOMEFs transducedwith iRhom2 retrovirus encoding the indicate
to stimulate shedding of TGF-a-AP.
(H) The iRhom2 S/A non-phosphorylatable mutants (used in G) had equivalent ex
Data are presented as mean ± SEM.
750 Cell Reports 21, 745–757, October 17, 2017of mature TACE (Figure 5G). Together, our data confirm that
14-3-3 protein recruitment is central to the mechanism whereby
iRhom2 phosphorylation at S83 controls TACE stimulation.
iRhom2 Phosphorylation Does Not Control iRhom/TACE
Trafficking to the Cell Surface
The recruitment of 14-3-3 proteins can exert distinct effects on
the trafficking fate of membrane proteins, including facilitating
their exit from the ER, or regulating their endocytosis (O’Kelly
et al., 2002; Gabriel et al., 2012). To investigate whether 14-3-3
protein recruitment to phosphorylated iRhom2 affected TACE
maturation (which requires its progression into the trans-Golgi
apparatus) or iRhom2 trafficking itself, we began by examining
the ability of iRhom2 phosphorylation mutants to promote
TACE trafficking to the trans-Golgi apparatus, where the prodo-
main of TACE is normally cleaved off by furin (Schlo¨ndorff et al.,
2000; Adrain et al., 2012). Notably, TACE maturation was not
impaired in iRhom DKO MEFs expressing a panel of non-phos-
phorylatable mutants (Figures 6A and 6B), confirming that
iRhom2 phosphorylation does not control TACE trafficking
from the ER to the trans-Golgi.
Our observations indicate that iRhom2 fulfills two important,
but separable, functions: its canonical role in the anterograde
trafficking of TACE, versus a distinct function, dependent on
iRhom2 phosphorylation, that controls the rapid stimulation of
TACE activity. Assuming that the effect elicited by iRhom2 phos-
phorylation impinges directly on TACE, the corollary is that
iRhom2 should be found on the cell surface, where TACE exerts
its sheddase activity. Immunofluorescent experiments describe
iRhom2 to be an intracellular, predominantly ER-localized pro-
tein (Zettl et al., 2011; Maney et al., 2015; Grieve et al., 2017).
However, two recent studies have found that overexpressed
forms of iRhom localize to the cell surface (Maney et al., 2015;
Grieve et al., 2017). We confirmed this result in flow cytometry
experiments, in unpermeabilized RAW267.4 murine macro-
phages stably expressing HA-tagged iRhom2 (Figure 6C).
As overexpression can risk artifactual spillover of membrane
proteins into other compartments, we investigated this phenom-
enon more stringently, using a cell-impermeable biotinylation
reagent to detect endogenous iRhom2 on the cell surface
(Figure 6D). Inhibiting dynamin-dependent endocytosis using
dynasore blocked iRhom2 degradation (Figures 6E and 6F), sup-
porting the hypothesis that, like TACE (Lorenzen et al., 2016), the
stability of iRhom2 is controlled by the endolysosomal system.
Our observations suggest that iRhom2 hence has the potential
to regulate TACE throughout the secretory pathway. However,Shedding Activity
d to alanine.
m2 are required for TACE shedding of TGF-a-AP in rescue assays in iRhom1/2
timulate shedding. EV, empty vector.
sion levels in iRhom1/2 DKO MEFs.
m2-HA, stably expressed in HEK293ET cells. Five of those identified are PMA
n = 2, Student’s t test.
d serine-to-alanine (S/A) single-point mutations PMA (30 and 60min) was used
pression levels in iRhom1/2 DKO MEFs.
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Figure 5. Phosphorylation-Dependent Recruitment of 14-3-3 to iRhom2 Induces Increased TACE Activity
(A) iRhom2-interacting proteins with altered binding upon PMA stimulation, detected by mass spectrometry, in iRhom2-HA immunoprecipitates; 14-3-3 proteins
are highlighted in blue. See Figure S1B for a more comprehensive view of this dataset (n = 2).
(B) Validation of PMA-inducible 14-3-3 binding to iRhom2. HEK293ET cells expressing an empty vector (EV) control, WT, or iRhom2-Dead-HA were stimulated
(PMA, 30 min). iRhom2-HA was immunoprecipitated and endogenous 14-3-3 binding detected with a pan-14-3-3 antibody.
(C) S83 is the major phosphorylated residue that recruits 14-3-3 proteins. HEK293ET cells expressing iRhom2-HA serine-to-alanine (S/A) mutants at the three
putative 14-3-3 binding sites (S60, S83, and S359) were stimulated with PMA (30 min), iRhom2-HA was immunoprecipitated and endogenous 14-3-3 binding
detected.
(D) Schematic of the R18-iRhom2 Dead mutant. The R18 peptide (PHCVPRDLSWLDLEANMCLP) was fused to the N terminus of iRhom2 Dead-HA mutant, to
confer phosphorylation independent binding of 14-3-3 proteins.
(E) The R18-iRhom2 Dead-HA mutant binds constitutively to endogenous 14-3-3 proteins. HEK293ET cells expressing the indicated plasmids were stimulated
(PMA, 30 min).
(F) 14-3-3 binding induces TACE cell surface proteolytic activity. HEK293ET cells overexpressing the indicated plasmids were left untreated. TACE
proteolytic activity on the cell surface was determined by measuring its ability to cleave a fluorogenic substrate. RFU, relative fluorescent units. Student’s
t test.
(G) TACE maturation is not affected by 14-3-3 binding. Lysates from iRhom1/2 DKO MEFs stably expressing the indicated plasmids were ConA enriched and
immunoblotted for TACE.
Data are presented as mean ± SEM. See also Figure S1.the amounts of cell surface iRhom2 and TACE appeared equiv-
alent in cells expressing WT versus the Dead mutant (Figures
S2A–SC), suggesting that iRhom2 phosphorylation does not
control the trafficking of iRhom2 or TACE to the cell surface.
Moreover, the rate of PMA-triggered loss of TACE from the cell
surface was not significantly different (Figures S2A and S2B),
and dynasore did not rescue shedding in the iRhom2 Dead
mutant, confirming that defective endocytosis or sorting to thelysosome could not account for the TACE shedding defect
(Figure S2D).
An important implication of these results is that the phosphor-
ylation mutants of iRhom2 are not misfolded, because the
iRhom2 Dead mutant was fully capable of supporting the traf-
ficking of itself and TACE throughout the secretory pathway.
By contrast, if iRhom2 phosphorylation mutants were misfolded,
their retention in the ER and degradation by ER-associatedCell Reports 21, 745–757, October 17, 2017 751
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Figure 6. iRhom2 Phosphorylation Regulates TACE Beyond the ER
(A) TACE maturation is not affected by iRhom2 phosphorylation in iRhom1/2 DKO MEFs stably expressing the indicated iRhom2 mutants.
(B) Densitometric scans illustrating the proportion of mature TACE in iRhom DKO MEFs expressing the indicated iRhom2 mutants.
(C) Flow cytometric detection of overexpressed cell surface iRhom2-HA in non-permeabilized RAW264.7 cells. Student’s t test. EV, empty vector.
(D) Cell surface biotinylation assays detecting endogenous cell surface iRhom2 in RAW264.7 macrophages.
(E) Consistent with cell surface localization, endogenous iRhom2 degradation upon treatment with a protein synthesis inhibitor (CHX, 50 mg/mL) is rescued by the
inhibitor of dynamin-dependent endocytosis dynasore (80 mM, co-treatment with CHX).
(F) Densitometry of (D).
Data are presented as mean ± SEM. See also Figure S2 and Table S2.degradation (ERAD) would cause the loss of their essential TACE
trafficking function, blocking TACEmaturation. Further evidence
that the iRhom2 Deadmutant is properly folded came frommass
spectrometry analysis of iRhom2 interacting proteins, revealing
that, apart from 14-3-3 proteins (as anticipated), the majority
(>93%) of proteins that interact with WT iRhom2 also bound
the iRhom2 Dead mutant (Table S2; Figures S1C and S1D).
Hence, blocking iRhom2 phosphorylation causes a specific
defect in the biology of TACE stimulation, without affecting the
biogenesis or trafficking of iRhom2 and TACE.
iRhom2 Phosphorylation Enhances TACE Activity
Independently of Substrate Recruitment by Promoting
Dissociation of TACE from iRhom2
As previously proposed (Lemberg and Adrain, 2016), our model
implies that iRhom2 remains associated with TACE at the cell
surface. As it has been suggested that stimulation controls
exposure of TACE’s active site (Le Gall et al., 2010), we hypoth-
esized that iRhom2 phosphorylation may be the mechanism
that facilitates TACE stimulation by exposing the TACE proteo-
lytic site to its substrates. To test this, we used an assay using a
fluorogenic TACE substrate added to the media of PMA-treated
cells. The assay specifically measured TACE activity upon
iRhom2 overexpression, because a TACE-specific short hairpin
RNA (shRNA) abrogated peptide cleavage, whereas knock-
down of ADAM10, TACE’s closest relative, did not affect pep-
tide hydrolysis (Figures S3A and S3B). Moreover, the assay752 Cell Reports 21, 745–757, October 17, 2017was sensitive to inhibition by the metalloprotease inhibitor
BB94, but not GI254023X, which has a 100-fold preference
for ADAM10 over TACE (Figures S3C and S3D). Compared
with cells expressing WT iRhom2, TACE activity in cells ex-
pressing the iRhom2 Dead mutant were defective in stimulated
TACE proteolytic activity (Figures 7A and 7B). This is significant
because it rules out the possibility that iRhom2 phosphorylation
is required for the recruitment of transmembrane TACE
substrates.
To assess the basis for how phosphorylation of iRhom2
rendered TACE more accessible to substrates in more detail,
we focused on the iRhom2 Dead mutant containing the ‘‘R18’’
14-3-3 recruitment motif, which constitutively binds to 14-3-3
(Figure 5E) and rescues the loss of function phenotype associ-
atedwith the iRhom2Deadmutant (Figure 5F). Similar to a recent
observation that iRhom phosphorylation promotes dissociation
of TACE from iRhom2 on the cell surface (Grieve et al., 2017),
we observed substantially reduced binding of mature TACE
to the R18-iRhom2 Dead mutant (Figure 7C). We also observed
a trend suggesting that the Dead mutant retained TACE more
efficiently than WT iRhom2 in response to PMA stimulation
(Figure 7C).
We next focused on the mechanism whereby 14-3-3 recruit-
ment triggers dissociation of TACE from iRhom2. As Grieve
et al. (2017) proposed that the cytoplasmic tail of iRhom2 was
specifically required for the binding to mature TACE, we exam-
ined which portions of TACE are needed for interaction with
AD
B C
Figure 7. iRhom2 Phosphorylation Regulates TACE Proteolytic Activity at the Cell Surface Independently of Substrate Delivery
(A) iRhom2-HA WT overexpression in HEK293ET cells, but not iRhom2-HA Dead, increases the ability of TACE to cleave a fluorogenic substrate added to the
culture media of PMA-stimulated cells. The metalloprotease inhibitor Batimastat (BB94) demonstrates the component of TACE activity conferred by iRhom2
overexpression. AU, arbitrary units.
(B) TACE cell surface proteolytic activity expressed as the rate of peptide cleavage (relative fluorescent units [RFU] per minute). Student’s t test.
(C) 14-3-3 binding induces dissociation of the iRhom2/TACE complex. HEK293ET cells expressing the indicated plasmids were stimulated (PMA, 30 min).
Dissociation of iRhom2/TACEwas assessed by a-HA immunoprecipitates. Bottom: densitometric quantification of the interaction between TACE and iRhom2, as
a percentage of binding to iRhom2 WT under non-stimulated conditions.
(D) Plasmids encodingWT V5 tagged TACE, ADAM10, or the indicated domain swap chimeras of TACE (red) and ADAM10 (blue) were transfected into HEK293ET
together with iRhom2-HA (+) or empty vector (). Binding of TACE, ADAM10, or chimeric constructs to iRhom2-HA was detected using anti-V5 antibody on anti-
HA IPs.
Data are presented as mean ± SEM. See also Figure S3.iRhom2 in co-immunoprecipitations. Significantly, we found that
the TACE transmembrane domain was the principal determinant
of binding to iRhom2: replacing the ADAM10 transmembrane
domain with that of TACE conferred binding of this chimeric
construct to iRhom2 (Figure 7D). By contrast, an ADAM10
chimera containing the TACE cytoplasmic tail could not bind to
iRhom2, implying, albeit indirectly, that the iRhom2 tail does
not play a major role in binding to the TACE tail (Figure 7D).
Together, we conclude that iRhom2 phosphorylation recruits
14-3-3 proteins, enforcing dissociation of iRhom from TACE,
via a mechanism dependent on transmembrane domain interac-tions, and rendering the active site of TACE more accessible to
its substrates.
DISCUSSION
Our data highlight the important regulatory role of the iRhom
cytoplasmic tail and suggests that it is an important signaling
hub. It is interesting to note that the iRhom2 cytoplasmic tail
contains predicted disordered segments (Figure S1A). Such
regions are often rich in protein interaction surfaces, including
14-3-3 binding sites, and are highly sensitive to inputCell Reports 21, 745–757, October 17, 2017 753
from signaling pathways, including phosphorylation-induced
conformational changes (Bozoky et al., 2013).
During the revision of our manuscript, Grieve et al. (2017) pub-
lished findings that reach similar conclusions to ours, although
our data differ from, and extend, those observations in several
ways. Our work establishes a physiological context in which
iRhom phosphorylation occurs, placing it within the settings of
infection (activation of Toll-like receptors by bacteria and vi-
ruses) and cancer (EGFR transactivation by G protein-coupled
receptors). Our objective identification of the phosphorylation
sites within iRhom2 is complementary to Grieve et al. (2017):
whereas our work maps the phosphorylated residues induced
upon TACE stimulation in mouse iRhom2, Grieve et al. (2017)
documented basal phosphorylation of residues within human
iRhom2.
Grieve et al. (2017) propose that the cytoplasmic tail of iRhom2
interacts with mature TACE. Arguing against this, our data show
that the transmembrane domain of TACE is necessary and suffi-
cient for binding to iRhom2, whereas the TACE cytoplasmic tail
is not. Moreover, although the TACE cytoplasmic tail is dispens-
able for stimulation, its transmembrane domain cannot be
substituted (Le Gall et al., 2010); single-point mutants within
TACE transmembrane domain impair stimulated shedding (Li
et al., 2017). Our interpretation is that recruitment of 14-3-3 pro-
teins to the iRhom2 tail triggers a cue that is transduced through
iRhom2, to weaken transmembrane interactions between TACE
and iRhom2, releasing TACE from the complex, facilitating its
access to substrates.
It is important to relate our observations to the mechanism
of TACE stimulation proposed by Sommer et al. (2016), who
showed that the membrane proximal domain of TACE has an
affinity for the phospholipid PS. TACE-activating stimuli trigger
PS externalization; the TACE membrane proximal domain binds
PS, provoking a conformational change, drawing TACE in closer
juxtaposition to its substrates (Sommer et al., 2016). Notably, as
blocking this PS-dependent mechanism impairs the cleavage of
transmembrane TACE substrates, but does not affect peptide
substrate hydrolysis (Sommer et al., 2016), it implies that our
iRhom-dependent mechanism is distinct from this. An additional
potential mechanism that has been proposed to explain the
stimulation mechanism involves the stimulus-induced dissocia-
tion of themetalloprotease inhibitor TIMP3 from TACE. However,
as the extent of TACE stimulation is identical in TIMP3 null cells
as in WT cells (Le Gall et al., 2010), we consider this possibility
unlikely.
There is evidence that iRhoms can govern the substrate spec-
ificity of TACE (Maretzky et al., 2013), and Grieve et al. (2017)
noted the possibility that phosphorylation of iRhom2 could influ-
ence substrate selection. We do not rule out the possibility that
some of themultiple phosphorylation sites within iRhomsmay in-
fluence substrate recruitment. However, because our phosphor-
ylation-defective iRhom2 Dead mutant cannot support TACE
cleavage of a peptide substrate, it suggests that a failure to re-
cruit transmembrane substrate to TACE is not the basis of the
defect.
Our observation that iRhom2 is at the core of the cell surface
shedding regulatory machinery reconciles the ambiguity that
TACE stimulation involves p38 and ERK kinases (Dı´az-Rodrı´guez754 Cell Reports 21, 745–757, October 17, 2017et al., 2002; Fan et al., 2003; Scott et al., 2011; Soond et al., 2005;
Xu et al., 2012; Fan and Derynck, 1999), yet its tail is dispensable
for stimulation (Le Gall et al., 2010; Hall and Blobel, 2012).
Consistent with a potential role forMAP kinases, the cytoplasmic
tail of iRhom2 contains two predicted ERK-D boxes (Figure S1A).
Similarly, our immunoprecipitation and mass spectrometry ex-
periments (Figure S4) detected the binding of kinases to iRhom1
and iRhom2, including ERK1, ERK2, and p38a, as well as binding
of RSK1 and RSK2 to iRhom2. However, we cannot conclude
that direct phosphorylation of iRhom2 by MAP kinases is key
to the TACE stimulation mechanism. From our analyses, the sin-
gle most important residue in iRhom2 for stimulated shedding is
serine 83, which harbors the site [K/R]-XX-[S/T] recognized by
the AGC kinase family members, such as RSK kinases, that
are activated downstream of ERK/p38 (Roux and Blenis, 2004;
Pearce et al., 2010). iRhom2 is phosphorylated in multiple resi-
dues; presumably several phosphorylation sites collectively
make additive contributions, as demonstrated by the iRhom2
Dead mutant, whose function is more profoundly blocked than
the S83A point mutant. Overall, we do not exclude the possibility
that phosphorylation of iRhom2 by several kinase families con-
trol stimulated TACE shedding.
Notably, our mass spectrometry experiments identified that
several residues within iRhom2, including S83, exhibit a degree
of basal phosphorylation in the absence of stimulation (Fig-
ure 4D). This raises the possibility that the basal activity of
TACE may also be regulated by iRhom2 phosphorylation.
Our observation that iRhom2 is phosphorylated is an example
of the dynamic regulation of rhomboid like proteins in the secre-
tory pathway by signaling pathways. A prior belief, from studies
that demonstrated that expression of rhomboid proteases pre-
figures signaling (Wasserman and Freeman, 1998), was that
rhomboid proteins are not subject to post-transcriptional regula-
tion. However, our work reveals that iRhoms are highly regulated
molecules. Interestingly, there are many parallels between the
regulation of iRhoms by their cytoplasmic tails and the regulation
of the important chloride channel, cystic fibrosis transmembrane
conductance regulator (CFTR). Like iRhom, CFTR contains a
cytoplasmic loop called the ‘‘R domain’’ (regulatory domain)
that is highly disordered, contains sites for phosphorylation
and 14-3-3 binding, and plays a key role in regulating CFTR ion
channel activity (Bozoky et al., 2013). Because of these striking
similarities, we propose to name the cytoplasmic tail of iRhoms
the regulatory (R) domain (Figure S5). Interestingly, the CFTR R
domain has been proposed to act as signaling hub not only for
pathways that regulate CFTR but as a general signaling platform.
It will be interesting to determine whether the same applies for
iRhoms.
The discovery that endogenous iRhom2 localizes to the cell
surface, and that its phosphorylation is required for shedding, re-
quires rethinking of the model for iRhom function. Rather than a
trafficking role restricted to the ER-to-Golgi transport of TACE,
the data now support a model whereby iRhom and TACE traffic
to the cell surface as a complex, allowing iRhom to fulfill a role in
sensing and transducing shedding stimuli to TACE (Figure S5).
Rather than acting as a TACE trafficking factor, iRhom’s role
could be regarded as analogous to the relationship between
the accessory subunits of multi-membrane protein complexes,
for example, gamma secretase, the T cell receptor, or MHC
class I. Similar to the examples above, loss of iRhom results in
the ER retention of TACE. Additionally, iRhom could be viewed
as an allosteric regulator of the TACE complex.
EXPERIMENTAL PROCEDURES
Mice
Experiments with mice were performed in accordance with protocols
approved by the IGC Ethics Committee and the National Entity Direc¸~ao Geral
de Alimentac¸~ao e Veterina´ria, in accordance with the Portuguese (Decreto-Lei
no. 113/2013) and European (directive 2010/63/EU) legislation related to
housing, husbandry, and animal welfare. iRhom2/ (KO)micewere previously
reported (Adrain et al., 2012).
Phos-tag Gels and Protein Dephosphorylation
Phos-tag gels were performed as described in Supplemental Experimental
Procedures.
Mass Spectrometry Analysis of iRhom2 Phosphorylation and
Phosphorylation-Dependent Interactome
HEK293ET cells expressing empty vector, iRhom2-HA WT, or iRhom2
Dead-HA were serum-starved overnight and stimulated with PMA (1 mM) for
15 min. Immunoprecipitations, sample digestion, and mass spectrometry
are described in Supplemental Experimental Procedures.
Cell Surface Biotinylation
Biotinylation was performed as previously described for bone marrow-derived
macrophages (BMDMs) (Adrain et al., 2012) with small modifications, detailed
in Supplemental Experimental Procedures.
Flow Cytometry
RAW264.7 macrophages (1 3 106) expressing empty vector or iRhom2-HA
were detached with a cell scraper, Fc-blocked, and stained with an anti-HA
primary antibody and Alexa 633-labeled secondary antibody. HEK293ET cells
expressing iRhom2-HA WT or iRhom2 Dead-HA were stained with a
phycoerythrin-conjugated anti-TACE primary antibody or isotype control
phycoerythrin-conjugated IgG1. Analysis details are provided in Supplemental
Experimental Procedures.
TACE Enzymatic Assay on Live Cells
The TACE enzymatic assay used an internally quenched fluorogenic peptide
based on the TNF cleavage site. Full experimental details are provided in Sup-
plemental Experimental Procedures.
Shedding Assays
MEFs were transfected with plasmids encoding alkaline phosphatase-tagged
EGFR ligands TGF-a and BTC (Sahin et al., 2006), as described in Supple-
mental Experimental Procedures.
Statistical Methods
Unless otherwise stated, all experiments were performed at least three times,
and statistical significance was determined using one-way ANOVA with
Tukey’smultiple comparison testing. Asterisks indicate statistical significance:
*p < 0.05, **p < 0.01, and ***p < 0.001.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and two tables and can be found with this article online at
https://doi.org/10.1016/j.celrep.2017.09.074.
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